The Institute of Cancer Research (ICR) shared a post on LinkedIn:
“News: Research reveals a potential drug to target a rare childhood brain tumour.
ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.
Read more about the research, funded by The Brain Tumour Charity.”
Source: The Institute of Cancer Research/LinkedIn
More posts featuring The Institute of Cancer Research on oncodaily.com